The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 8,801–8,900 of 31,469
Even Low-Intensity and Low-Volume Exercise Training May Improve Insulin Resistance in the Elderly
Kodama, S., Shu, M., Saito, K., Murakami, H., Tanaka, K., Kuno, S., Ajisaka, R., Sone, Y., Onitake, F., Takahashi, A., et al. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0096 · Cited by 41
Gletsu-Miller, N. A., Lin, E., Zhu, J.-L., Khaitan, L., Ramshaw, B., FARMER, P. K., Ziegler, T. R., Papanicolaou, D. A., & Smith, C. D. (2006) · Surgery · doi:10.1016/j.surg.2006.01.018 · Cited by 41
Yang, X., Yang, G., Wang, W., Chen, G., & Yang, H. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0938-7 · Cited by 41
Lee, S., Lee, Y., Kim, K. J., Lee, W., Kwon, O., & Kim, J. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2378-6 · Cited by 41
Androutsos, O., Moschonis, G., Mavrogianni, C., Roma-Giannikou, E., Chrousos, G. P., Kanaka‐Gantenbein, C., & Μanios, Y. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.280 · Cited by 42
Vaidya, D. M., Szklo, M., Cushman, M., et al. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.47 · Cited by 41
Vitamin D status and glucose homeostasis in obese children and adolescents living in the tropics
Poomthavorn, P., Saowan, S., Mahachoklertwattana, P., Chailurkit, L., & Khlairit, P. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.260 · Cited by 41
Urinary benzene metabolite and insulin resistance in elderly adults
Choi, Y., Kim, J. H., Lee, B.-E., & Hong, Y. (2014) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2014.02.121 · Cited by 40
Luo, D., Liu, F., Li, X., Yin, D., Lin, Z., Liu, H., Hou, X., Wang, C., & Jia, W. (2014) · Endocrine · doi:10.1007/s12020-014-0444-2 · Cited by 56
Prakash, J., Srivastava, N., Awasthi, S., et al. (2012) · American Journal of Human Biology · doi:10.1002/ajhb.22245 · Cited by 41
Andréasson, A., Undén, A., Elofsson, S., & Brismar, K. (2012) · American Journal of Human Biology · doi:10.1002/ajhb.22279 · Cited by 42
Metabolic Health Is More Closely Associated with Coronary Artery Calcification than Obesity
Rhee, E., Seo, M. H., Kim, J. D., Jeon, W. S., Park, S. E., Park, C., Oh, K.-W., Park, H., & Lee, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074564 · Cited by 41
Sun, L., Hu, C., Zheng, C., Qian, Y., Liang, Q., Lv, Z., Huang, Z., Qi, K., Gong, H., Zhang, Z., et al. (2015) · Scientific Reports · doi:10.1038/srep09852 · Cited by 41
Kamimura, M. A., Carrero, J. J., Canziani, M. E. F., Watanabe, R., Lemos, M. M., & Cuppari, L. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.06.004 · Cited by 41
van Vliet, M., von Rosenstiel, I. A., Schindhelm, R. K., Brandjes, D. P. M., Beijnen, J. H., & Diamant, M. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-2 · Cited by 41
Roos, C., Lidfeldt, J., Agardh, C., Nyberg, P., Nerbrand, C., Samsioe, G., & Westrin, Å. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.013 · Cited by 41
Breen, L., Philp, A., Shaw, C. S., Jeukendrup, A. E., Baar, K., & Tipton, K. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020613 · Cited by 44
Borel, A., Monneret, D., Tamisier, R., Baguet, J.-P., Faure, P., Levy, P. A., Halimi, S., & Pépin, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071000 · Cited by 40
Oka, R., Yagi, K., Sakurai, M., Nakamura, K., Nagasawa, S., Miyamoto, S., Nohara, A., Kawashiri, M., Hayashi, K., Takeda, Y., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12294 · Cited by 42
Palou, M., Torrens, J. M., Priego, T., Sánchez, J., Palou, A., & Picó, C. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.05.001 · Cited by 41
Schultz, A., Barbosa‐da‐Silva, S., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2015) · Food & Function · doi:10.1039/c5fo00251f · Cited by 42
The Effect of Exercise on Serum Levels of Interleukin-18 and Components of the Metabolic Syndrome
Trøseid, M., Lappegård, K. T., Mollnes, T. E., Arnesen, H., & Seljeflot, I. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0003 · Cited by 41
Blüher, S., Petroff, D., Wagner, A., Warich, K., Gausche, R., Klemm, T., Wagner, M., & Keller, A. (2013) · Metabolism · doi:10.1016/j.metabol.2013.11.016 · Cited by 41
Rouvinen‐Watt, K., Mustonen, A., Conway, R., Pal, C., Harris, L., Saarela, S. Y. O., Strandberg, U., & Nieminen, P. (2009) · Lipids · doi:10.1007/s11745-009-3377-4 · Cited by 41
Borel, A., Nazare, J., Smith, J. D., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., & Després, J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.024 · Cited by 41
Habib, M. Z., Shaker, S. M., Elgayar, N., & Aboul‐Fotouh, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120559 · Cited by 45
Purslane extract effects on obesity-induced diabetic rats fed a high-fat diet.
Abdalla, H. M. (2010) · PubMed · Cited by 41
Huguenin, G. V. B., & Rosa, G. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510000851 · Cited by 41
Leptin concentrations are a predictor of overweight reduction in a lifestyle intervention
Reinehr, T., Kleber, M., de Sousa, G., & Andler, W. (2009) · International Journal of Pediatric Obesity · doi:10.3109/17477160902952464 · Cited by 40
Pinar, M., Gülsün, M., Taşçı, İ., Erdil, A., Bolu, E., Açıkel, C., & Doruk, A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.028 · Cited by 41
Bo, S., Gambino, R., Durazzo, M., Ghione, F., Musso, G., Gentile, L., Cassader, M., Cavallo‐Perin, P., & Pagano, G. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346397 · Cited by 41
Barbero-Fernández, A., Astiz, S., López-Bote, C. J., Pérez-Solana, M. L., Ayuso, M., Real, I. G., & Gonzalez‐Bulnes, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078424 · Cited by 42
Health Consequences of Childhood Obesity
Saha, A. K., Sarkar, N., & Chatterjee, T. (2011) · The Indian Journal of Pediatrics · doi:10.1007/s12098-011-0489-7 · Cited by 42
Gouni‐Berthold, I., Berthold, H. K., Chamberland, J. P., Krone, W., & Mantzoros, C. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03080.x · Cited by 41
Vinet, A., Obert, P., Dutheil, F., Diagne, L., Chapier, R., Lesourd, B., Courteix, D., & Walther, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2704 · Cited by 41
Sakr, H. F. (2013) · PubMed · Cited by 41
Androulakis, I., Kandaraki, E., Christakou, C., Karachalios, A., Marinakis, E., Paterakis, T., & Diamanti-Kandarakis, E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12447 · Cited by 46
Huang, T., Huang, J., Qi, Q., Li, Y., Bray, G. A., Rood, J. C., Sacks, F. M., & Qi, L. (2014) · Diabetes Care · doi:10.2337/dc14-0473 · Cited by 42
Jehle, S., Lardi, A. M., Felix, B., Hulter, H. N., Stettler, C., & Krapf, R. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13942 · Cited by 41
Beydoun, M. A., Kuczmarski, M. F., Wang, Y., Mason, M. A., Evans, M. K., & Zonderman, A. B. (2010) · Public Health Nutrition · doi:10.1017/s1368980010002648 · Cited by 41
Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS
Çağlar, G. S., Kahyaoğlu, İ., Pabuçcu, R., Demırtaş, S., & Şeker, R. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2833-9 · Cited by 42
Dobs, A. S., Goldstein, B. J., Aschner, P. J., Horton, E. S., Umpierrez, G. E., DURAN, L., HILL, J. S., Chen, Y., Golm, G. T., Langdon, R. B., et al. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00223.x · Cited by 41
You, S. C., Kim, K. J., Kim, S. U., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., & Han, K. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12992 · Cited by 41
Panidis, D., Τζιόμαλος, Κ., Chatzis, P., Papadakis, E. P., Delkos, D., Tsourdi, E. A., Kandaraki, E., & Katsikis, I. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0655 · Cited by 41
Rao, M. N., Mulligan, K. M., Tai, V., Wen, M., Dyachenko, A., Weinberg, M. E., Li, X., Lang, T., Grünfeld, C., Schwarz, J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2502 · Cited by 41
Jocken, J. W. E., Roepstorff, C., Goossens, G. H., van der Baan, P., van Baak, M. A., Saris, W. H. M., Kiens, B., & Blaak, E. E. (2008) · Diabetes · doi:10.2337/db07-0857 · Cited by 43
Metabolic Effects of Replacing Sucrose by Isomaltulose in Subjects With Type 2 Diabetes
Brunner, S., Holub, I., Theis, S., Gostner, A., Melcher, R., Wolf, P., Amann‐Gassner, U., Scheppach, W. M., & Hauner, H. (2012) · Diabetes Care · doi:10.2337/dc11-1485 · Cited by 41
da Silva, I. T., Timm, A. D. S., & Damasceno, N. R. T. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-19 · Cited by 41
Bringhenti, I., Schultz, A., Rachid, T. L., Bomfim, M. A. D., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.08.013 · Cited by 42
Houde, A.-A., Ruchat, S.-M., Allard, C., Baillargeon, J., St‐Pierre, J., Perron, P., Gaudet, D., Brisson, D., Hivert, M., & Bouchard, L. (2015) · Epigenomics · doi:10.2217/epi.15.72 · Cited by 40
Karelis, A. D., Hébert, M., RABASA-LHORET, R. P. R., & Räkel, A. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.08.014 · Cited by 41
Type 2 diabetes is associated with postprandial amino acid measures
Mook-Kanamori, D. O., de Mutsert, R., Rensen, P. C. N., Prehn, C. P., Adamski, J., den Heijer, M., le Cessie, S., Suhre, K., Rosendaal, F. R., & van Dijk, K. W. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.08.003 · Cited by 40
Metformin may protect nondiabetic breast cancer women from metastasis
El-Haggar, S. M., El‐Shitany, N. A., Mostafa, M. F., & El‐Bassiouny, N. A. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9782-1 · Cited by 42
Kizirian, N. V., Kong, Y., Muirhead, R., Brodie, S., Garnett, S. P., Petocz, P., Sim, K. A., Celermajer, D. S., Louie, J. C. Y., Markovic, T., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.123695 · Cited by 42
Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study
Erol, O. Ö., Erkal, N., Elli̇dağ, H. Y., İsenlik, B. S., Aydın, Ö., Derbent, A. U., & Yılmaz, N. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2016.1142967 · Cited by 41
Nielsen, T. S., Theil, P. K., Purup, S., Nørskov, N. P., & Knudsen, K. E. B. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b03372 · Cited by 41
Fadaee, S. B., Beetham, K. S., Howden, E. J., Stanton, T., Isbel, N. M., & Coombes, J. S. (2016) · Redox Report · doi:10.1080/13510002.2016.1173326 · Cited by 41
The Effect of Normobaric Hypoxic Confinement on Metabolism, Gut Hormones, and Body Composition
Mekjavić, I. B., Amon, M., Kölegård, R., Kounalakis, S. N., Simpson, L., Eiken, O., Keramidas, M. E., & Macdonald, I. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00202 · Cited by 41
Prakash, J., Mittal, B., Srivastava, A. N., Awasthi, S., & Srivastava, N. (2016) · Oman Medical Journal · doi:10.5001/omj.2016.20 · Cited by 43
Hwang, I., Park, H. E., & Choi, S. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.36467 · Cited by 39
Copeptin in obese children and adolescents: relationships to body mass index, cortisol and gender
Rothermel, J., Kulle, A. E., Holterhus, P., Toschke, C., Lass, N., & Reinehr, T. (2016) · Clinical Endocrinology · doi:10.1111/cen.13235 · Cited by 44
Luo, Y., Li, L., Xu, X., Wu, T., Yang, M., Zhang, C., Mou, H., Zhou, T., Jia, Y., Cai, C., et al. (2016) · Clinical Science · doi:10.1042/cs20160543 · Cited by 41
Pregnancy to postpartum transition of serum metabolites in women with gestational diabetes
Chorell, E., Andersson-Hall, U. K., Gustavsson, C., Berntorp, K. E., Puhkala, J., Luoto, R. M., Olsson, T., & Holmäng, A. B. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.018 · Cited by 40
Serum uromodulin is associated with impaired glucose metabolism
Leiherer, A., Muendlein, A., Saely, C. H., Kinz, E., Brandtner, E. M., Fraunberger, P., & Drexel, H. (2017) · Medicine · doi:10.1097/md.0000000000005798 · Cited by 41
Zhang, L., Fu, Y., Zhou, N., Cheng, X., & Chen, C. (2017) · Endocrine · doi:10.1007/s12020-017-1324-3 · Cited by 41
Gentili, A., Frangione, M. R., Albini, E., Vacca, C., Ricci, M. A., VUONO, S. D., Boni, M., Rondelli, F., Rotelli, L., Lupattelli, G., et al. (2017) · Translational research · doi:10.1016/j.trsl.2017.06.001 · Cited by 41
Abdominal subcutaneous adipose tissue cellularity in men and women
Andersson, D. P., Arner, P., Hogling, D. E., Rydén, M., & Arner, P. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.148 · Cited by 43
Ruijgrok, C., Dekker, J. M., Beulens, J. W. J., Brouwer, I. A., Coupé, V. M. H., Heymans, M. W., Sijtsma, F. P. C., Mela, D. J., Zock, P. L., Olthof, M. R., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4452-7 · Cited by 42
SİVA, Z. O., Uludüz, D., Keskin, F. E., Erenler, F., Balcı, H., Uygunoğlu, U., Saip, S., Göksan, B., & Sıva, A. (2017) · Cephalalgia · doi:10.1177/0333102417748928 · Cited by 43
Kabat, G. C., Kim, M., Lane, D. S., et al. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000435 · Cited by 41
Anthropometric and Dietary Factors as Predictors of DNA Damage in Obese Women
Włodarczyk, M., Jabłonowska-Lietz, B., Olejarz, W., & Nowicka, G. (2018) · Nutrients · doi:10.3390/nu10050578 · Cited by 41
Insulin Resistance and the Risk of Diabetes and Dysglycemia in Korean General Adult Population
Baek, J. H., Kim, H., Kim, K. Y., & Jung, J. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.0106 · Cited by 43
Cifre, M., Palou, A., & Oliver, P. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0246-8 · Cited by 40
The relationship between metabolic syndrome and asthma in the elderly
Park, S., Choi, N., Kim, S., & Lee, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-26621-z · Cited by 39
Flister, K. F. T., Pinto, B., França, L. M., Coêlho, C. F. F., dos Santos, P. C., Vale, C. C., Kajihara, D., Debbas, V., Laurindo, F. R. M., & Paes, A. M. D. A. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.09.007 · Cited by 42
Racial discrimination, body mass index, and insulin resistance: A longitudinal analysis.
Brody, G. H., Yu, T., Chen, E., Ehrlich, K. B., & Miller, G. E. (2018) · Health Psychology · doi:10.1037/hea0000674 · Cited by 40
Sakaue, A., Adachi, H., Enomoto, M., Fukami, A., Kumagai, E., Nakamura, S., Nohara, Y., Kono, S., Nakao, E., Morikawa, N., et al. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318810020 · Cited by 41
Associations Between Cannabis Use and Cardiometabolic Risk Factors: A Longitudinal Study of Men
Meier, M. H., Pardini, D. A., Beardslee, J., & Matthews, K. A. (2018) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000665 · Cited by 41
Valdés, S., Doulatram‐Gamgaram, V. K., Lago-Sampedro, A. M., Torres, F. G., Badía-Guillén, R., Olveira, G., Goday, A., Calle‐Pascual, A. L., Castaño, L. A., Castell, C., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0818 · Cited by 45
Shah, M. A., Reanmongkol, W., Radenahmad, N., Khalil, R., Ul‐Haq, Z., & Panichayupakaranant, P. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108702 · Cited by 41
Epigenetic regulation of diabetogenic adipose morphology
Kerr, A. G., Sinha, I., Dadvar, S., Arner, P., & Dahlman, I. A. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.04.009 · Cited by 42
Maillard, F., Vazeille, E., Sauvanet, P., Sirvent, P., Combaret, L., Sourdrille, A., Chavanelle, V., Bonnet, R., Otero, Y. F., Delcros, G., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214660 · Cited by 45
Calcaterra, V., Montalbano, C., Silvestri, A. D., Pelizzo, G., Regalbuto, C., Paganelli, V., Albertini, R., Cave, F. D., Larizza, D., & Cena, H. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2019.0024 · Cited by 41
Mayer, C., Côme, M., Ulmann, L., Zittelli, G. C., Faraloni, C., Nazih, H., Ouguerram, K., Chénais, B., & Mimouni, V. (2019) · Nutrients · doi:10.3390/nu11051069 · Cited by 44
Characterization of a highly effective preparation for suppression of myocardial glucose utilization
Larson, S. R., Pieper, J. A., Hulten, E. A., et al. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01786-w · Cited by 41
Sung, J., Lee, D. Y., Min, K. P., & Park, C. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.09.005 · Cited by 42
Estradiol regulates daily rhythms underlying diet-induced obesity in female mice
Omotola, O. B., Legan, S. J., Slade, E., Adekunle, A. D., & Pendergast, J. S. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00365.2019 · Cited by 44
Prakash, S., Rai, U., Kosuru, R., Tiwari, V. K., & Singh, S. (2019) · Biochimie · doi:10.1016/j.biochi.2019.11.005 · Cited by 42
Wutthi-in, M., Cheevadhanarak, S., Yasom, S., Kerdphoo, S., Thiennimitr, P., Phrommintikul, A., Chattipakorn, N., Kittichotirat, W., & Chattipakorn, S. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-67078-3 · Cited by 46
Fathi, M., Alavinejad, P., Haidari, Z., & Amani, R. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126635 · Cited by 41
Succurro, E., Miceli, S., Fiorentino, T. V., Sciacqua, A., Perticone, M., Andreozzi, F., & Sesti, G. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01248-z · Cited by 41
Tragni, E., Vigna, L., Ruscica, M., Macchi, C., Casula, M., Santelia, A., Catapano, A. L., & Magni, P. (2021) · Nutrients · doi:10.3390/nu13061804 · Cited by 44
Ren, X., Wang, L., Chen, Z., Zhang, M., Hou, D., Xue, Y., Diao, X., Liu, R., & Shen, Q. (2021) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.07.013 · Cited by 46
Prevalence of prediabetes in children and adolescents by class of obesity
Pedicelli, S., Fintini, D., Ravà, L., Inzaghi, E., Deodati, A., Spreghini, M. R., Bizzarri, C., Mariani, M., Cianfarani, S., Cappa, M., et al. (2022) · Pediatric Obesity · doi:10.1111/ijpo.12900 · Cited by 41
Tran, S. K., Toan, N. H., Thang, N., Tuong, H. L. T., Tien, H. A., Thuy, N. H., Minh, H. V., & Valensi, P. E. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01509-5 · Cited by 42
Chen, R.-A., Wu, W., Panyod, S., Liu, P., Chuang, H.-L., Chen, Y., Lyu, Q., Hsu, H., Lin, T., Shen, T. D., et al. (2022) · mSystems · doi:10.1128/msystems.00172-22 · Cited by 43
Metabolic Disorders Associated with Obstructive Sleep Apnea in Adults
(2011) · Advances in cardiology · doi:10.1159/000325106 · Cited by 41
Yamada, C., Moriyama, K., & Takahashi, E. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00194.x · Cited by 41
Miyatake, N., Takahashi, K., Wada, J., Nishikawa, H., Morishita, A., Suzuki, H., Kunitomi, M., Makino, H., Kira, S., & Fujii, M. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00176-1 · Cited by 41
Decreased Basal Levels of Glucagon-Like Peptide-1 after Weight Loss in Obese Subjects
de Luis, D. A., Sagrado, M. G., Conde, R., Aller, R., & Izaola, O. (2007) · Annals of Nutrition and Metabolism · doi:10.1159/000103273 · Cited by 41
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
